Allspring Global Investments’s Veracyte VCYT Stock Holding History
Bought
Maintained
Sold
Other funds holding VCYT
AIM
Allspring Global Investments's VCYT Position: Q2 2026 in Review
Allspring Global Investments increased its Veracyte (VCYT) stake by 3% in Q2 2026, buying an estimated $18.9K and bringing the position to 15,674 shares worth $938K. The position accounts for ﹤0.01% of the portfolio, ranked #1263.
Allspring Global Investments first reported a position in VCYT in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.91M in Q4 2021. 370 funds tracked by Wall St. Rank hold VCYT as of Q2 2026.
- Allspring Global Investments held 15,674 shares of Veracyte worth $938K as of Q2 2026.
- Allspring Global Investments bought 450 Veracyte shares in Q2 2026, an estimated $18.9K.
- Veracyte made up ﹤0.01% of Allspring Global Investments's portfolio in Q2 2026, its #1263 holding.
- Allspring Global Investments first reported a position in Veracyte in Q4 2021 and has held it in 19 quarters since.
- Allspring Global Investments's Veracyte position peaked at $3.91M in Q4 2021.
- 370 funds tracked by Wall St. Rank held Veracyte as of Q2 2026.
Based on Allspring Global Investments's 13F filing for Q2 2026, filed 13 Aug 2026.